Enhancement of antisense oligonucleotide-mediated exon skipping as a therapy for Duchenne muscular dystrophy

Project: Research

StatusFinished
Effective start/end date6/02/175/02/20

Funding

UCB Biopharma SPRL: £55,500

ID: 27768405